NewsRx

Search our medical news database

Cancer Law Weekly

Susan Hasty, Publisher

Table of Contents . . . March 11th, 2006

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Law Weekly | Other Publications

Beijing Institute of Radiation Medicine - Adenoviral-mediated gene transfer results in cytotoxicity of multiple myeloma cells

Celera Genomics Group - Abbott has selected two additional cancer targets for development, genomics firm reports

Health Discovery Corp. - New U.S. patent covers SVM-based image analysis

M.D. Anderson Cancer Center - A GSTP1 polymorphism may be linked to survival in advanced non-small cell lung carcinoma

U.S. National Institutes of Health - Accumulating evidence indicates that MLBCL and cHL are related entities

Zopharm Oncology, Inc - Second U.S. patent issued for cancer treatment using organic arsenic plus other agents

AEterna Zentaris, Inc. - Cancer drug developer's strategic shareholder exercises right to convert loan

Access Pharmaceuticals, Inc. - Tumor therapy developer completes $5M convertible offering

Adventrx Pharmaceuticals, Inc. - CoFactor phase IIb trial surpasses 50% enrollment milestone

Affymax, Inc. - Agreement signed to develop and commercialize Hematide in Japan

Akita University - Magnetometer enabled in vivo sentinel lymph node mapping in lung cancer patients

American Cancer Society - American Cancer Society reports drop in total U.S. cancer deaths

American University of the Caribbean, Coral Gables - Morphology and DNA degeneration during autoschizic cell death in bladder cancer described

Belcolle Hospital, Viterbo - Gemcitabine and cisplatin found effective in treating elderly patients with lung cancer

Bioniche Life Sciences Inc. - U.S. FDA accepts first part of phase 3 trials with MCC-DNA complex for bladder cancer

Breast Cancer - Alliance publishes international breast health guidelines for developing countries

Breast Cancer - Study examines racial disparities among breast cancer patients

CHU la Milétrie, Poitiers - Imatinib mesylate effective in CML in late chronic and advanced phase and after SCT relapse

CSIC, Madrid - Vav/Rho GTPase signaling activation controls dependent melanoma cell invasion

Cedars-Sinai Medical Center, Los Angeles - Research uncovers pathway to overcome brain tumor resistance to cell death

Centre Rene Gauducheau, Nantes - Oral uracil/ftorafur plus leucovorin treated metastatic colorectal cancer

Centro de Biologia Molecular Estrutural, Campinas - Hepatitis B virus protein HBx interacts with the human transcription regulatory protein p120E4F

Children's Hospital of Philadelphia - Methodology presented for quantification of Act-D and VCR in pediatric cancers

Children's Hospital of Wisconsin - Use of alternative donor transplants in children with early Ph+ ALL encouraged

Chinese University of Hong Kong - RASSF1A modulated genes identified in nasopharyngeal carcinoma

Cleveland Clinic Foundation - Intensity-modulated radiation therapy used to treat intracranial meningiomas

Clinical Institute of Nephrology and Urology - Sirolimus reduces risk of cancer in kidney transplant patients, published study shows

College of Medicine, Omaha - Antisense-cisplatin combination treatment is potentially useful in breast cancer

Colon Cancer - Doctors fail to recommend colon cancer tests for low-income patients

Cornell University, Ithaca - H-1 magnetic resonance spectroscopic imaging can assess glioma response to chemotherapy

CytoCore, Inc. - InPath System developer inks research agreement with University Hospitals of Cleveland

CytoCorp, Inc. - Cancer screening systems developer changing its name to CytoCore

Cytogen Corp. - Letter of intent executed for marketing of SOLTAMOX

Dana-Farber Cancer Institute, Boston - Bortezomib uses alternate signals to control multiple myeloma angiogenesis

Dana-Farber Cancer Institute, Boston - Long-acting octreotide used to treat bowel obstruction in ovarian cancer

Davis School of Medicine, Sacramento - Reports advance knowledge in prostate cancer research

Debiopharm, SA - Promising results reported from Debio-025 trial in HIV-1-infected subjects

Delcath Systems, Inc. - Melanoma trial receives NCI Institutional Review board approval

Diagnostics - Studies describe new findings in diagnostics research

Dip Epidemiologia, Rome - Kaposi sarcoma risk higher in HIV/AIDS than in transplant recipients

Disease Associations - Choice of age cut-off for dyspepsia may decrease endoscopy workload

Disease Associations - Paget disease of bone diagnosed in patient with known prostate cancer

Dong-A University College of Medicine, Busan - TRAIL recombinant adenovirus displays antitumor activity in human malignant glioma cells

Duke University, Durham - New findings in drug development described

Eckert & Ziegler, AG - Cancer-focused firm receives large-scale contract for cancer afterloaders in Venezuela

End-of-Life Issues - Concordance of preferences between cancer patient and family for end-of-life care estimated

End-of-Life Issues - Factors predicting home death for terminally ill cancer patients identified

Erasmus University, Rotterdam - Three new human BRCA1 mutant cell lines could aid in understanding the function of BRCA1

European Center for the Validation of Alternative Methods - Perchloroethylene exposure affects various pathways involved in cancer induction

Facilities - New Jersey hospital opens new $17 million Monter Cancer Center

Fred Hutchinson Cancer Research Center - Allogeneic hematopoietic cell transplantation is a therapy for hematologic malignancies

Fudan University, Shanghai - Cathepsin B and its interacting proteins implicated in apoptosis of ovarian cancer cells

G Gaslini Institute, Children's Hospital, Genoa - Clinical use of CXCR4 antagonists to prevent neuroblastoma metastasis is not supported

Genzyme Corp. - Test available to monitor Gleevec resistance in people with CML

Geron Corp. - Commercial launch of telomerase-immortalized cell line through ATCC announced

GlaxoSmithKline - IV Hycamtin receives European marketing approval for relapsed small cell lung cancer

Hamedan University of Medicine - Results from a 10-year study of squamous cell carcinoma in Hamedan analyzed

Harvard University Medical School - First disease-specific protein library opens new path for drugs to fight breast cancer

Haukeland University Hospital, Bergen - Endostatin inhibits angiogenesis in a species-specific fashion

Henry Ford Hospital, Detroit - Depression does not affect survival among patients with pancreatic cancer

Herzzentrum Lahr - HIF-2 alpha signal transduction in ovarian cancer cells might not involve Bcl-2A

Hopital Edouard Herriot, Lyon - ET-743 proposed as novel agent with activity in soft tissue sarcomas

Hospital Clinic of Barcelona - Positron emission tomography used to detect bone marrow involvement in lymphoma

Hospital for Sick Children, Toronto - No specific imaging features found for intracranial atypical teratoid/rhabdoid tumors

Hull Royal Infirmary, Kingston Upon Hull - Incidence of detecting pulmonary embolisms with CT in oncology patients analyzed

INSERM U563, Toulouse - Therapeutic targeting of RhoB may control tumor hypoxia and proliferation

Indiana University - The VEGF receptor inhibitor AZD2171 diminished breast tumor size in cancer models

Institute for Cancer Research, London - Findings describe new data in leukemia research

Institute of Hematology and Blood Transfusion, Prague - DNA vaccines carrying HPV16 E7 peptide protect against cervical tumors

International Agency for Research on Cancer, Lyon - Primary glioblastomas show similar genetic alterations in patients in Japan and Switzerland

Istanbul University - Expression of bcl-2 used to prognosticate papillary thyroid cancers

Istanbul University - Fragmented nucleosomal DNA unrelated to caspase-3 mRNA in lymphoma and myeloma

Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan - Role of gamma-glutamyltransferase expression in cancer cells and drug resistance explored

Istituto di Ricerche Farmacologiche Mario Negri, Milan - Association between aspirin use and lowered risk of prostate cancer unsupported

J.W. Goethe University, Frankfurt - Researchers develop guidelines for treatment of breast cancer during pregnancy

John Wayne Cancer Institute, Santa Monica - CCL21 adjuvant enhances immunogenicity of DNA melanoma vaccine

Johns Hopkins University - Germ-line mutations of NKV3.1 implicated in risk of hereditary prostate cancer

Johns Hopkins University - Oleanolic derivative compound protects against liver cancer

Johns Hopkins University Hospital - CT guided percutaneous renal tumor cryoablation effective in initial clinical use

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook